MedTrace Logo

Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression

NCT01579942 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2017-03-06

No results posted yet for this study

Summary

The investigators are doing this study to find out if they can use electroencephalographic (EEG) recordings, which measure brain waves, to predict response to antidepressant treatments, as well as to distinguish patients who have depression from those who do not. In particular the investigators want to test the usefulness of a new type of analysis of EEG recordings called brain network activation or BNA. BNA allows to identify patterns of activation in brain networks and to track their changes over time.

Conditions

Sponsors & Collaborators

  • ElMindA Ltd

    collaborator INDUSTRY

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Cristina Cusin, MD · Massachusetts General Hospital

  • Ottavio Vitolo, MD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01579942 on ClinicalTrials.gov